Skip to main content
12 Jul | 2022

The BBRC participates in the annual meeting of the International Neuropsychological Society

BBRC researchers present four posters and three oral presentations at INS 2022, which this year took place in Barcelona under the theme “Global Innovations in Science and Practice”.

30 Jun | 2022

The AMYPAD study performs amyloid PET tests on 840 European participants

The research center of the Pasqual Maragall Foundation, the BBRC, participates in the project, together with seven other European centers.

27 Jun | 2022

We participate in the World Summit on Neurodegenerative Diseases NEURO 2020/2022

During the congress, basic, clinical and translational aspects of research in neurodegenerative diseases were discussed.

17 Jun | 2022

The BBRC hosts a European symposium on the latest technologies in biomarkers

The participants of the conference were able to see first-hand the center's new Fluid Biomarkers and Translational Neurology laboratory.

14 Jun | 2022

Dr. Marta del Campo, appointed Director of the BBRC Fluid Biomarkers Platform

La investigadora tindrà la responsabilitat de desenvolupar, validar i implementar biomarcadors en sang per a la detecció precoç de l’Alzheimer.

09 Jun | 2022

Dr. Marc Suárez-Calvet receives the "2021 Alzheimer Award" from the SEN

The award recognizes the leadership, work and key contributions in the field of biochemical biomarkers of the researcher.

31 May | 2022

Dr. Eider Arenaza-Urquijo talks about brain resilience at the Science Festival

The BBRC researcher has offered a micro-lecture on how lifestyle habits and mental health affect the brain's ability to prevent neurodegenerative diseases.

30 May | 2022

Outstanding participation of the BBRC in the XVIII Spanish Biometrics Conference

At this conference, dedicated to scientific techniques for measuring the parameters of living beings, researchers from the Neurobiogenetics team presented three talks and a poster.

19 May | 2022

A CNIC project in collaboration with the BBRC receives an Alzheimer's Disease Research Standard Award from the BrightFocus Foundation

The project focuses on the longitudinal determination of plasma biomarkers of neuronal damage, neuroinflammation and Alzheimer's disease.